Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JDB0131 in Drug-Susceptible Pulmonary Tuberculosis
CTR20232010Phase 2Completed
- Sponsor
- Changzhou Yinsheng Pharmaceutical
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JDB0131 in pulmonary tuberculosis (TB), sponsored by Changzhou Yinsheng Pharmaceutical. Started Jul 2023; status: completed.
02
Drugs
JDB0131
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20232010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232010.